-- 根據多家媒體報道,與伊朗有關的油輪「Rich Starry」號在離開霍爾木茲海峽一天后,於週三改變航向,而美國在波斯灣外的封鎖仍然有效。 這艘駛往中國的油輪及其船東上海宣潤航運有限公司因與伊朗石油貿易有關而受到美國制裁。 根據路透社報道,這艘中程油輪據稱從阿聯酋哈姆裡亞港裝載了25萬桶甲醇,並於週二成為美國封鎖開始後首艘離開霍爾木茲海峽的船隻。封鎖於美國東部時間週一上午10點開始。 然而,根據Seatrade Maritime News報道,這艘油輪週三被發現駛回霍爾木茲海峽,而不是繼續駛入阿拉伯海。 EOS Risk Group諮詢主管馬丁凱利在X網站上表示,該船「突然」改變航向,表明美國的封鎖「仍然有效」。 路透社引述航運數據顯示,除「Rich Starry」號外,另有兩艘受美國制裁的船隻——「Peace Gulf」號和「Murlikishan」號——於週二通過了霍爾木茲海峽。 路透社稱,這三艘與伊朗有關聯的船隻並非駛往伊朗港口,因此不應封鎖。 負責執行經濟和貿易制裁的美國財政部外國資產管制辦公室尚未回覆的置評請求。 此外,週二還有五艘船通過了這一咽喉要道。路透社稱,這些船隻包括兩艘化學品和液化氣油輪、兩艘乾散貨船以及一艘停靠在伊朗阿巴斯港的貨船。 據報道,週二共有至少八艘船通過了霍爾木茲海峽。 路透社引述一位美國官員的話報道,同一天,美國海軍在阿曼灣的恰巴哈爾港攔截了兩艘油輪,並命令它們掉頭進入伊朗港口。 美國中央司令部在X網站上發文稱,“在最初的24小時內,沒有船隻突破美國的封鎖,六艘商船遵照美軍的指示掉頭,重新進入阿曼灣的伊朗港口。” 同時,據路透社看到的一份美國軍方文件顯示,人道物資運輸不受美國封鎖的限制。 據報道,自美國實施封鎖以來,穿越霍爾木茲海峽的船隻數量一直保持在極低水平,遠低於戰前每天超過130艘的水平。
Related Articles
Scotiabank Previews This Week's February and Preliminary March GDP for Canada
Canada reports gross domestic product for February and the preliminary estimate for March on Thursday, said Scotiabank.February was initially guided by Statistics Canada to have been tracking a 0.2% month-over-month gain last month. Updated estimates are still in the same ballpark, but investors also get important details on sector drivers, noted the bank.More meaningful may be the flash guidance, with no details, for March GDP, for which there is very little information so far, but a small gain is "feasible," stated Scotiabank.The outcome will further inform Q1 GDP growth tracking on a production/income basis using monthly GDP. It's feasible that growth is tracking close to the Bank of Canada's 1.8% January Monetary Policy Report estimate, but that's on an expenditure basis. The massive over 4% inventory drag on Q4 GDP could reverse as an added upside, pointed out the bank.One key is that consumer spending on goods is tracking a strong rebound in Q1 based on retail sales volumes. It's untrue that the economy isn't exhibiting rate sensitivity, a view that is disproportionately driven by a false understanding of what's keeping condo markets weak in Toronto and Vancouver, added Scotiabank.
Vicor Insider Sold Shares Worth $2,079,226, According to a Recent SEC Filing
Alvaro Doyle, Vice President and Chief Information Officer, on April 23, 2026, sold 8,000 shares in Vicor (VICR) for $2,079,226. Following the Form 4 filing with the SEC, Doyle has control over a total of 42 common shares of the company, with 42 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/751978/000182673026000002/xslF345X05/primary_doc.xmlPrice: $265.29, Change: $-8.24, Percent Change: -3.01%
BioMarin Seen Building Broader Rare-Disease Platform After Amicus Deal, Morgan Stanley Says
BioMarin Pharmaceutical (BMRN) is emerging as a broader rare-disease platform as its acquisition of Amicus Therapeutics (FOLD) adds two approved medicines and reduces reliance on Voxzogo, Morgan Stanley said Monday in a report.The Amicus deal reshapes BioMarin's outlook by adding Galafold and Pombiliti with Opfolda, products that fit the company's global commercial network, the report said. The therapies are expected to generate more than $1.3 billion in revenue by 2030, Morgan Stanley said.The acquisition is projected to accelerate revenue growth immediately after closing and to be accretive to non-GAAP earnings within 12 months, with "substantial accretion" beginning in 2027, the report said. BioMarin closed its $4.8 billion purchase of Amicus on Monday.Morgan Stanley resumed coverage on BioMarin stock with an overweight rating and a $120 price target.Price: $54.08, Change: $+0.90, Percent Change: +1.68%